Comparison of the action of two new oral diuretics, the 4-chloro-N-methyl-3-(methylsulfamoly) benzamide and 4-chloro-3-sulfamylbenzoic acid 2,2-dimethylhydrazide (a study on 102 patients).
D000328:Adult; D000368:Aged; D001158:Arteries; D001786:Blood Glucose; D001794:Blood Pressure; D001835:Body Weight; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy* / Q000209:etiology; D006333:Heart Failure / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008875:Middle Aged; D009318:Natriuresis; D009401:Nephrosis / Q000150:complications; D011188:Potassium / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014882:Water-Electrolyte Balance
D001786:Blood Glucose; D004232:Diuretics; D014527:Uric Acid; D011188:Potassium